/

Vividion Therapeutics

Developing drugs for oncology and immunology using chemoproteomics.

BiotechnologyPharmaceuticals vividion.com ↗

Company facts

Founded: 2016
Employees: 270
Headquarters: United States
Type: Private
Funding: Series C · $135M · 2021
Subsidiaries: Tavros Therapeutics